Relief Therapeutics Holding AG (RLFTF)

[Biohunter21]

A question about a patent is a legitimate question. Should this drug be approved, any analyst is going analyze what type of profit and for how long to figure out their price targets and make buying/selling decisions.

With that, the most important thing right now is seeing positive data coming out, the patent issue and modeling earnings will be a good problem to have, but that’s not where this is right now... I’m hopeful we do get there though.